Filtered By:
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 1725 results found since Jan 2013.

Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment
Curr Stem Cell Res Ther. 2022 Nov 24. doi: 10.2174/1574888X18666221124122113. Online ahead of print.ABSTRACTCoronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 with severe respiratory failure and organ damage that later appeared as a pandemic disease. Worldwide, people's mental and physical health and socioeconomic have been affected. Currently, with no promising treatment for COVID-19, the existing anti-viral drugs and vaccines are the only hope to boost the host immune system to reduce morbidity and mortality rate. Unfortunately, several reports ...
Source: Current Stem Cell Research and Therapy - November 25, 2022 Category: Stem Cells Authors: Vignesh Balaji E Sairaj Satarker Tanvi V Gujaran Jeena John Anuranjana P V Krupa Thankam George Divya K P Fathima Beegum Anna Mathew R J A Vibhavari Sneha Sunil Chaudhari K Sreedhara Ranganath Pai Source Type: research

Optimizing the use of Paxlovid in clinical practice
Drugs Today (Barc). 2022 Nov;58(11):539-546. doi: 10.1358/dot.2022.58.11.3461265.ABSTRACTOn December 22, 2021, the United States Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for nirmatrelvir/ritonavir (Paxlovid) for the treatment of mild to moderate coronavirus disease 2019 (COVID-19). The drug is authorized for use in patients 12 years of age and older weighing at least 40 kg who have tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and who are at high risk for progression to severe COVID-19. Nirmatrelvir, an orally bioavailable protease inhibitor that prev...
Source: Drugs of Today - November 24, 2022 Category: Drugs & Pharmacology Authors: M W McCarthy Source Type: research